Antonio Cubillo
Impact in
- Oncology top 5%
- Pancreatic and Hepatic Oncology Research
- Colorectal Cancer Treatments and Studies
- Cancer Cells and Metastasis
- Cancer Immunotherapy and Biomarkers
- Cancer Research top 10%
- Cancer Genomics and Diagnostics
Papers in
- Oncology 75
- Colorectal Cancer Treatments and Studies 34
- Pancreatic and Hepatic Oncology Research 24
- Cancer Treatment and Pharmacology 16
-
- Lung Cancer Treatments and Mutations 9
- Co-authors
- Jesús Rodríguez-Pascual (15 shared papers)Manuel Hidalgo (18 shared papers)Yolanda Quijano (13 shared papers)Rafael Álvarez (6 shared papers)Fernando López‐Ríos (10 shared papers)Carlos Plaza (6 shared papers)E. Vicente (3 shared papers)Pedro P. López‐Casas (3 shared papers)
- Journals
- Journal of Clinical Oncology (30 papers)Annals of Oncology (17 papers)European Journal of Cancer (4 papers)Clinical & Translational Oncology (3 papers)Investigational New Drugs (3 papers)
- Partner nations
- SpainUnited StatesFrance
In The Last Decade
Antonio Cubillo
85 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 74
- Oncology 864
- Cancer Research 233
- Pulmonary and Respiratory Medicine 253
- Surgery 248
- Immunology 118
Countries citing papers authored by Antonio Cubillo
This map shows the geographic impact of Antonio Cubillo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antonio Cubillo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antonio Cubillo more than expected).
Fields of papers citing papers by Antonio Cubillo
This network shows the impact of papers produced by Antonio Cubillo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antonio Cubillo. The network helps show where Antonio Cubillo may publish in the future.
Co-authors
The 25 scholars most cited alongside Antonio Cubillo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 88 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 237 | |
| 2 | 2018 | 74 | |
| 3 | 2017 | 57 | |
| 4 | 2016 | 46 | |
| 5 | 2017 | 45 | |
| 6 | 2014 | 44 | |
| 7 | 2020 | 37 | |
| 8 | 2018 | 36 | |
| 9 | 2021 | 33 | |
| 10 | 2018 | 33 | |
| 11 | 2023 | 33 | |
| 12 | 2001 | 31 | |
| 13 | 2005 | 28 | |
| 14 | 2012 | 24 | |
| 15 | 2012 | 23 | |
| 16 | 2017 | 22 | |
| 17 | 2016 | 20 | |
| 18 | 2020 | 17 | |
| 19 | 2020 | 14 | |
| 20 | 2014 | 14 |
About Antonio Cubillo
Antonio Cubillo is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Surgery and Epidemiology, having authored 88 papers that have together received 1.1k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (34 papers), Pancreatic and Hepatic Oncology Research (24 papers), Cancer Genomics and Diagnostics (17 papers), Cancer Treatment and Pharmacology (16 papers), Cancer Research and Treatments (10 papers), Lung Cancer Treatments and Mutations (9 papers), Hepatocellular Carcinoma Treatment and Prognosis (7 papers) and Genetic factors in colorectal cancer (7 papers). The work is most often cited by research in Oncology (864 citations), Cancer Research (233 citations), Pulmonary and Respiratory Medicine (253 citations), Surgery (248 citations) and Immunology (118 citations). Antonio Cubillo has collaborated with scholars based in Spain, United States and France. Frequent co-authors include Jesús Rodríguez-Pascual, Manuel Hidalgo, Yolanda Quijano, Rafael Álvarez, Fernando López‐Ríos, Carlos Plaza, E. Vicente, Pedro P. López‐Casas, Elena García-García and Mariano Barbacid. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, European Journal of Cancer, Clinical & Translational Oncology and Investigational New Drugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.